Shoulder DislocationNCT03585491
Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation
A study testing Latarjet Procedure and Bankart + Remplissage Procedure in people with Shoulder Dislocation and Sport Injuries, run by Moin Khan at 1 site in Canada.
Trial summary
The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period. Read more about this study
- Who is it for?
- Ages 18 to 50 years
- Conditions the study is for
- Shoulder Dislocation, Sport Injuries, Shoulder
- What is being tested?
- Latarjet Procedure and Bankart + Remplissage Procedure
- Type of treatment
- Pill or oral medicine, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 86 participants
- Where
- 1 siteCanada
- Study dates
- 1 Jul 2019to 1 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Men and women ages 18-50 years;
- Diagnosis of post-traumatic recurrent anterior dislocation. This will require a minimum of 2 episodes of documented dislocations either by radiographic evidence or documented reduction of anterior shoulder dislocation as well as physical examination eliciting unwanted glenohumeral translation with reproduction of symptoms;
- Mild glenoid bone loss as defined on CT by standardized and reproducible best-fit circle technique (>10% but <20%);
- Provision of informed consent.
Who cannot join
- Patients with concomitant injuries (cuff tear);
- Previous shoulder surgery;
- Patients that will likely have problems, in the judgment of the investigators, with maintaining follow-up;
- Epilepsy;
- Patients who are or at risk of being incarcerated;
- Diagnosis of multidirectional instability;
Show all 9Show fewer
- Cases involving litigation or workplace insurance claims (e.g. WSIB);
- Confirmed connective tissue disorder (Ehlers-Danlos, Marfans) or Beighton hypermobility score > 6.
- Pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.
Read the detailed description
Background:
Shoulder is a highly mobile joint with the most directional range of movement compared to other joints in the body. Thus, the surrounding supporting structures of the shoulder joint compromise on the stability of the joint, in order to accomplish this wide range of motion.
Anterior dislocations, the most common type of shoulder dislocation, are often complicated by instability, and repeated dislocations. Shoulder instability results in pain and negatively impacts quality of life. Several long-term studies have demonstrated a relationship between the repeated dislocations and the risk of arthritis.
Surgical stabilization of the shoulder improves function and may reduce the risk of developing degenerative arthritis. Two procedures are commonly performed in patients with repeated dislocations: a bony transfer procedure (Latarjet) or a soft tissue procedure (Bankart + Remplissage). The Latarjet procedure involves transferring bone to the front of the shoulder. The Bankart + Remplissage procedure involves tightening the soft tissues at the front of the shoulder joint.
Although retrospective clinical studies have suggested a reduced recurrence rate with the Latarjet procedure, there is a higher reported complication rate and potential morbidity associated with the open procedure. Several case series from high-volume surgeons in Europe have suggested the Latarjet repair to be an acceptable and potentially favorable surgical approach for all cases of recurrent anterior shoulder dislocation, even in the primary setting and in the absence of significant glenoid cup bone loss. Retrospective analysis of soft tissue repair in comparison to open coracoid (Latarjet) procedure found at 10-year follow up, redislocation rates were 13% (36) of 271 shoulders with a Bankart repair and 1% (1) of the 93 shoulders with a Latarjet repair.
Need for a Pilot Study Prior to a Large Trial:
No comparative randomized control trial has been completed evaluating Bankart repair in comparison to Latarjet procedure in the setting of mild to moderate bone loss. Thus, surgeons face uncertainty regarding which procedure to perform. The Latarjet is more invasive (larger incision) and some research suggests it may be more effective at treating instability. The Bankart procedure, while minimally invasive (smaller incision), may result in higher rates of instability after surgery.
Prior to a large trial, the investigators will conduct a pilot trial comparing arthroscopic capsuloligamentous repair (Bankart Procedure) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period. This research will provide surgeons with new information regarding the best treatment for recurrent shoulder dislocation.
Study Aims and Objectives:
A pilot study is needed prior to a large trial to determine the feasibility of a larger trial in terms of:
- Ability to recruit across clinical sites
- Adherence to study protocol and,
- Ability to follow participants for 24 months
The trial will also compare arthroscopic capsuloligamentous repair (Bankart + Remplissage Procedure) vs. coracoid transfer (Latarjet procedure) on:
- Rates of recurrent shoulder dislocations and symptoms of instability up to 24 months' post- surgery;
- Clinical outcomes measured by Western Ontario Shoulder Instability (WOSI) Index, American Shoulder and Elbow Society (ASES) score;
- Physical examination: range of motion, strength, stability;
- Return to previous level of activity;
- Rate of shoulder-related complications and serious adverse events.
Study Design:
The investigators propose a multi-center pilot Randomized Clinical Trial of 82 patients across Canada, United States and Europe to compare the effect of capsuloligamentous repair (Bankart + Remplissage procedure) and coracoid transfer (Latarjet procedure) in patients with post-traumatic recurrent anterior dislocation. Eligible and consenting participants will be followed-up by the site for 24 months. Outcomes will be assessed at 2 weeks, 3 months, 6 months, 12 months, and 24 months post-surgery. Eligible participants will be randomized to one of two treatment groups:
- Arthroscopic capsuloligamentous repair (Bankart + Remplissage Procedure)
- Open or Arthroscopic coracoid transfer (Latarjet Procedure)
Once participants have provided informed consent, baseline demographics, relevant medical history, and details regarding their diagnosis will be collected from the participant, the attending surgeon, their medical record and through physical examination. Participants will also complete The Western Ontario Shoulder Instability Index (WOSI) and he American Shoulder and Elbow Surgeons questionnaire (ASES) at the time of enrolment.
After surgery, surgical and peri-operative details will be collected from the attending surgeon and the participant's medical records. Adverse events occurring during the surgical procedure or perioperative period will also be documented.
- Conditions
- Shoulder Dislocation, Sport Injuries, Shoulder, Anterior Dislocation
- Being tested
- Latarjet Procedure, Bankart + Remplissage Procedure
- Medical subject headings
- Shoulder Dislocation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Latarjet ProcedureProcedure or surgery
Participants will undergo open or arthroscopic Latarjet procedure.
Bankart + Remplissage ProcedureProcedure or surgery
Participants will undergo arthroscopic stabilization.
| Study group | Role | What they receive |
|---|---|---|
| Bankart + Remplissage Procedure | Experimental | Bankart Procedure: the participant will be placed in the lateral decubitus or beach chair position. Standard diagnostic arthroscopy will be performed. The anterior capsulolabral complex will be freed from the anterior aspect of the scapular neck. The anterior aspect of the scapular neck will be decorticated using a motorized burr. A capsuloligamentous repair will be performed with the capsule shifted from inferior to superior and repaired on the glenoid face. The number of anchors used for the repair will be left to the discretion of the surgeon. Patients will be given a sling for 4 weeks, and participation in sports will not be allowed for 6 months. Receives: Procedure: Bankart + Remplissage Procedure |
| Latarjet Procedure | Experimental | Open or Arthroscopic coracoid transfer (Latarjet Procedure): This procedure may be performed through small incisions (minimally invasive) but may require a larger incision in some cases. It involves the transfer of a nearby bony structure (the coracoid process) to the front of the shoulder joint (glenoid). This bone will then provide support to prevent the shoulder joint from dislocating. Receives: Procedure: Latarjet Procedure |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment Feasibility
Number of patients recruited
Measured: 10 months
Protocol Adherence
Number of errors in randomization
Measured: 2 years
Follow-up
Proportion of participants followed at two years
Measured: 2 years
Secondary outcomes (3)
Rate of Recurrence
Rate of recurrent dislocation and symptomatic instability between patients randomized to (capsuloligamentous repair + remplissage) and those receiving open Latarjet procedure.
Measured: 2 years
Clinical Outcome
Measured by Western Ontario Shoulder Instability (WOSI) Index
Measured: 2 years
Clinical Outcome
Measured by American Shoulder and Elbow Society (ASES) score
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jul 2018
- Study start1 Jul 2019
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Shoulder DislocationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 86 participants (actual)
Sponsor and investigators
- Lead sponsor
- Moin Khan
- Sponsor type
- University, hospital or other
- Collaborators
- St. Joseph's Healthcare Hamilton, University of Western Ontario, Canada, The Ottawa Hospital, Pan Am Clinic, University of Colorado, Denver, Queen's University, Sunnybrook Health Sciences Centre, Boston University, Deventer Ziekenhuis, Banff Sport Medicine Foundation, McMaster University, Brantford General Hospital, London Health Sciences Centre, Parc de Salut Mar, Hospital Universitari de Bellvitge, Hospital de Terrassa, Hospital Mutua de Terrassa, Pontificia Universidad Catolica de Chile, Endeavor Health, Medstar Health Research Institute, Hospital Universitari Vall d'Hebron Research Institute
- Responsible party
- Sponsor-investigator, Moin Khan, McMaster University
- Investigators
- Moin Khan, MD, Principal investigator, McMaster University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03585491
- Sponsor's protocol ID
- STABLE
- Status last verified
- Sep 2025
- First submitted
- 28 Jun 2018
- Last updated
- 26 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Khan M, Bedi A, Degen R, Warner J, Bhandari M; STABLE Investigators. A pilot multicenter randomized controlled trial comparing Bankart repair and remplissage with the Latarjet procedure in patients with subcritical bone loss (STABLE): study protocol. Pilot Feasibility Stud. 2022 Jan 31;8(1):20. doi: 10.1186/s40814-022-00987-4.
PubMed 35101120
Study at a glance
From the registry record, last updated by the sponsor on 26 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation
- ClinicalTrials.gov ID
- NCT03585491
- Acronym / sponsor ID
- STABLE
- Conditions
- Shoulder Dislocation, Sport Injuries, Shoulder, Anterior Dislocation
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 86 participants (actual)
- Lead sponsor
- Moin KhanUniversity, hospital or other
- Collaborators
- St. Joseph's Healthcare Hamilton, University of Western Ontario, Canada, The Ottawa Hospital, Pan Am Clinic, University of Colorado, Denver, Queen's University, Sunnybrook Health Sciences Centre, Boston University, Deventer Ziekenhuis, Banff Sport Medicine Foundation, McMaster University, Brantford General Hospital, London Health Sciences Centre, Parc de Salut Mar, Hospital Universitari de Bellvitge, Hospital de Terrassa, Hospital Mutua de Terrassa, Pontificia Universidad Catolica de Chile, Endeavor Health, Medstar Health Research Institute, Hospital Universitari Vall d'Hebron Research Institute
- Study start
- 1 Jul 2019 (actual)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Dec 2027 (estimated)
- First posted
- 13 Jul 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.
Detailed description
Background:
Shoulder is a highly mobile joint with the most directional range of movement compared to other joints in the body. Thus, the surrounding supporting structures of the shoulder joint compromise on the stability of the joint, in order to accomplish this wide range of motion.
Anterior dislocations, the most common type of shoulder dislocation, are often complicated by instability, and repeated dislocations. Shoulder instability results in pain and negatively impacts quality of life. Several long-term studies have demonstrated a relationship between the repeated dislocations and the risk of arthritis.
Surgical stabilization of the shoulder improves function and may reduce the risk of developing degenerative arthritis. Two procedures are commonly performed in patients with repeated dislocations: a bony transfer procedure (Latarjet) or a soft tissue procedure (Bankart + Remplissage). The Latarjet procedure involves transferring bone to the front of the shoulder. The Bankart + Remplissage procedure involves tightening the soft tissues at the front of the shoulder joint.
Although retrospective clinical studies have suggested a reduced recurrence rate with the Latarjet procedure, there is a higher reported complication rate and potential morbidity associated with the open procedure. Several case series from high-volume surgeons in Europe have suggested the Latarjet repair to be an acceptable and potentially favorable surgical approach for all cases of recurrent anterior shoulder dislocation, even in the primary setting and in the absence of significant glenoid cup bone loss. Retrospective analysis of soft tissue repair in comparison to open coracoid (Latarjet) procedure found at 10-year follow up, redislocation rates were 13% (36) of 271 shoulders with a Bankart repair and 1% (1) of the 93 shoulders with a Latarjet repair.
Need for a Pilot Study Prior to a Large Trial:
No comparative randomized control trial has been completed evaluating Bankart repair in comparison to Latarjet procedure in the setting of mild to moderate bone loss. Thus, surgeons face uncertainty regarding which procedure to perform. The Latarjet is more invasive (larger incision) and some research suggests it may be more effective at treating instability. The Bankart procedure, while minimally invasive (smaller incision), may result in higher rates of instability after surgery.
Prior to a large trial, the investigators will conduct a pilot trial comparing arthroscopic capsuloligamentous repair (Bankart Procedure) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period. This research will provide surgeons with new information regarding the best treatment for recurrent shoulder dislocation.
Study Aims and Objectives:
A pilot study is needed prior to a large trial to determine the feasibility of a larger trial in terms of:
- Ability to recruit across clinical sites
- Adherence to study protocol and,
- Ability to follow participants for 24 months
The trial will also compare arthroscopic capsuloligamentous repair (Bankart + Remplissage Procedure) vs. coracoid transfer (Latarjet procedure) on:
- Rates of recurrent shoulder dislocations and symptoms of instability up to 24 months' post- surgery;
- Clinical outcomes measured by Western Ontario Shoulder Instability (WOSI) Index, American Shoulder and Elbow Society (ASES) score;
- Physical examination: range of motion, strength, stability;
- Return to previous level of activity;
- Rate of shoulder-related complications and serious adverse events.
Study Design:
The investigators propose a multi-center pilot Randomized Clinical Trial of 82 patients across Canada, United States and Europe to compare the effect of capsuloligamentous repair (Bankart + Remplissage procedure) and coracoid transfer (Latarjet procedure) in patients with post-traumatic recurrent anterior dislocation. Eligible and consenting participants will be followed-up by the site for 24 months. Outcomes will be assessed at 2 weeks, 3 months, 6 months, 12 months, and 24 months post-surgery. Eligible participants will be randomized to one of two treatment groups:
- Arthroscopic capsuloligamentous repair (Bankart + Remplissage Procedure)
- Open or Arthroscopic coracoid transfer (Latarjet Procedure)
Once participants have provided informed consent, baseline demographics, relevant medical history, and details regarding their diagnosis will be collected from the participant, the attending surgeon, their medical record and through physical examination. Participants will also complete The Western Ontario Shoulder Instability Index (WOSI) and he American Shoulder and Elbow Surgeons questionnaire (ASES) at the time of enrolment.
After surgery, surgical and peri-operative details will be collected from the attending surgeon and the participant's medical records. Adverse events occurring during the surgical procedure or perioperative period will also be documented.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Bankart + Remplissage Procedure | Experimental | Procedure: Bankart + Remplissage ProcedureBankart Procedure: the participant will be placed in the lateral decubitus or beach chair position. Standard diagnostic arthroscopy will be performed. The anterior capsulolabral complex will be freed from the anterior aspect of the scapular neck. The anterior aspect of the scapular neck will be decorticated using a motorized burr. A capsuloligamentous repair will be performed with the capsule shifted from inferior to superior and repaired on the glenoid face. The number of anchors used for the repair will be left to the discretion of the surgeon. Patients will be given a sling for 4 weeks, and participation in sports will not be allowed for 6 months. |
| Latarjet Procedure | Experimental | Procedure: Latarjet ProcedureOpen or Arthroscopic coracoid transfer (Latarjet Procedure): This procedure may be performed through small incisions (minimally invasive) but may require a larger incision in some cases. It involves the transfer of a nearby bony structure (the coracoid process) to the front of the shoulder joint (glenoid). This bone will then provide support to prevent the shoulder joint from dislocating. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Men and women ages 18-50 years;
- Diagnosis of post-traumatic recurrent anterior dislocation. This will require a minimum of 2 episodes of documented dislocations either by radiographic evidence or documented reduction of anterior shoulder dislocation as well as physical examination eliciting unwanted glenohumeral translation with reproduction of symptoms;
- Mild glenoid bone loss as defined on CT by standardized and reproducible best-fit circle technique (>10% but <20%);
- Provision of informed consent.
Key exclusion criteria (9 listed)
- Patients with concomitant injuries (cuff tear);
- Previous shoulder surgery;
- Patients that will likely have problems, in the judgment of the investigators, with maintaining follow-up;
- Epilepsy;
- Patients who are or at risk of being incarcerated;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Latarjet ProcedureParticipants will undergo open or arthroscopic Latarjet procedure. | Procedure or surgery | Latarjet Procedure |
| Bankart + Remplissage ProcedureParticipants will undergo arthroscopic stabilization. | Procedure or surgery | Bankart + Remplissage Procedure |
Primary outcome
Recruitment Feasibility
Time frame: 10 months
Number of patients recruited
Protocol Adherence
Time frame: 2 years
Number of errors in randomization
Follow-up
Time frame: 2 years
Proportion of participants followed at two years
3 secondary outcomes
Rate of Recurrence
Time frame: 2 years
Clinical Outcome
Time frame: 2 years
Clinical Outcome
Time frame: 2 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Sep 2025.
- Derived from this study: PubMed 35101120Khan M, Bedi A, Degen R, Warner J, Bhandari M; STABLE Investigators. A pilot multicenter randomized controlled trial comparing Bankart repair and remplissage with the Latarjet procedure in patients with subcritical bone loss (STABLE): study protocol. Pilot Feasibility Stud. 2022 Jan 31;8(1):20. doi: 10.1186/s40814-022-00987-4.
- Individual participant dataSharing planned: No
Related trials for Shoulder Dislocation
Recruiting
SMR Stemless Reverse vs SMR Reverse Shoulder System
Arthroplasty, Replacement
RecruitingObservational study
Prospective Descriptive Study of Injuries Associated to Anterior Shoulder Dislocations in Patients Over 40 Years
Anterior Glenohumeral Dislocations
Not yet recruiting
Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode.
Shoulder Dislocation
Recruiting
Validation of an Upper Extremity Physical Performance Test Battery in Patients After Shoulder Dislocation
Return to Sport, Shoulder Dislocation or Subluxation
RecruitingObservational study
Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up
Proximal Humeral Fracture, Fracture Dislocation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Moin Khan, MD principal investigator
McMaster University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Latarjet Procedure and Bankart + Remplissage Procedure in people with Shoulder Dislocation and Sport Injuries, run by Moin Khan at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 26 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment Feasibility (time frame: 10 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03585491, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2025.